CD, D., JT, D., PH, P., DJ, C., MS, H., AC, P., . . . Z, S. (2024). Laryngeal Cancer Cells Metabolize 25-Hydroxyvitamin D3 and Respond to 24R,25-dihydroxyvitamin D3 via a Mechanism Dependent on Estrogen Receptor Levels. Cancers, 16(9), . https://doi.org/10.3390/cancers16091635
Chicago Style (17th ed.) CitationCD, Dennis, Dillon JT, Patel PH, Cohen DJ, Halquist MS, Pearcy AC, Boyan BD, and Schwartz Z. "Laryngeal Cancer Cells Metabolize 25-Hydroxyvitamin D3 and Respond to 24R,25-dihydroxyvitamin D3 via a Mechanism Dependent on Estrogen Receptor Levels." Cancers 16, no. 9 (2024). https://doi.org/10.3390/cancers16091635.
MLA (9th ed.) CitationCD, Dennis, et al. "Laryngeal Cancer Cells Metabolize 25-Hydroxyvitamin D3 and Respond to 24R,25-dihydroxyvitamin D3 via a Mechanism Dependent on Estrogen Receptor Levels." Cancers, vol. 16, no. 9, 2024, https://doi.org/10.3390/cancers16091635.